All patients (n = 1,391) | Patients with HMOD (n = 547) | Patients without HMOD (n = 844) | P value | |
---|---|---|---|---|
Oral antihypertensive drugs | 268 (19.3) | 106 (19.4) | 162 (19.2) | 0.932 |
Calcium antagonistsa | 170 (12.2) | 38 (6.9) | 132 (15.6) | < 0.001 |
Beta-blockerb | 62 (4.5) | 31 (5.7) | 31 (3.7) | 0.078 |
Renin-angiotensin system inhibitorc | 22 (1.6) | 13 (2.4) | 9 (1.1) | 0.056 |
Nitroglycerin | 73 (5.2) | 54 (9.9) | 19 (2.3) | < 0.001 |
Intravenous antihypertensive drugs | 619 (44.5) | 432 (79.0) | 187 (22.2) | < 0.001 |
Nicardipine | 453 (32.6) | 297 (54.3) | 156 (18.5) | < 0.001 |
Labetalol | 35 (2.5) | 28 (5.1) | 7 (0.8) | < 0.001 |
Esmolol | 14 (1.0) | 12 (2.2) | 2 (0.2) | < 0.001 |
Nitroglycerin | 211 (15.2) | 173 (31.6) | 38 (4.5) | < 0.001 |
Cessation due to iatrogenic hypotension | 71 (5.1) | 41 (7.5) | 30 (3.6) | 0.048 |